IP Library Granted Patent US 11,573,227
Granted Patent B2
US 11,573,227 · App. 17/149,227 · Granted Feb 7, 2023

Peptides and methods for the detection of Lyme disease antibodies

Inventors: Rajesh K. Mehra (Hayward, CA); Kenneth P. Aron (San Francisco, CA); Dennis M. Bleile (San Ramon, CA); Jeremy Walker (Castro Valley, CA); Cristina Cuesico (Fremont, CA)
Assignee: ZOETIS SERVICES LLC
G01N33/56911C07K14/20G01N2333/20G01N2469/20Y02A50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,573,227
App. No.
17/149,227
Granted
Feb 7, 2023
Kind
B2
Abstract

The invention provides compositions (e.g., peptide compositions) useful for the detection of antibodies that bind to Borrelia antigens. The peptide compositions comprise polypeptide sequences comprising variants in the IR6 domain of the Borrelia VlsE protein. The invention also provides devices, methods, and kits comprising such peptide compositions and useful for the detection of antibodies that bind to Borrelia antigens and the diagnosis of Lyme disease.

Claims (12)

1. A method for detecting in a sample an antibody to an epitope of a Borrelia antigen, the method comprising: contacting a sample with a mixture of isolated peptides comprising three or more different isolated peptides, wherein each isolated peptide comprises

(i) a sequence according to L-K-K-D-D-N-I-A-A-A-X 11 -V-L-R-G-X 16 -X 17 -K-D-G-X 21 -F-A-X 24 -X 25 (SEQ ID NO: 1) wherein X 11 is an amino acid selected from the group consisting of V and L, X 16 is an amino acid selected from the group consisting of L and I, X 17 is an amino acid selected from the group consisting of A and V, X 21 is an amino acid selected from the group consisting of R, D and N, X 24 is an amino acid selected from the group consisting of I, W, and Y, and X 25 is an amino acid selected from the group consisting of K and R;

(ii) an N-terminal peptide sequence wherein the sequence is n1-n2-S-P-n5-n6-P (SEQ ID NO: 149) or a fragment thereof, wherein n1 is an amino acid selected from the group consisting of A and V, n2 is an amino acid selected from the group consisting of E and D, n5 is an amino acid selected from the group consisting of K and R, and n6 is an amino acid selected from the group consisting of K and R; and

(iii) a C-terminal peptide sequence wherein the sequence is

(a) V-c2-E-G-c5-Q-Q-E-G-A-Q-Q-P-S-C(SEQ ID NO: 150) or a fragment thereof, wherein c2 is an amino acid selected from the group consisting of Q and R, and c5 is an amino acid selected from the group consisting of V and A; or

(b) A-V-c3-E-G-c6-Q-Q-E-G-A-Q-Q-P-S(SEQ ID NO: 151) or a fragment thereof, wherein C3 is an amino acid selected from the group consisting of Q and R, and C6 is an amino acid selected from the group consisting of V and A; and

detecting formation of an antibody-peptide complex comprising one or more isolated peptides in the mixture,

wherein formation of said complex is indicative of an antibody to an epitope of Borrelia antigen being present in said sample.

2. The method of claim 1 , wherein said Borrelia antigen is from a Borrelia burgdorferi, Borrelia afzelli , or Borrelia garinii species.

3. The method of claim 1 , wherein said detecting step comprises (i) performing an ELISA assay, (ii) running a lateral flow assay, (iii) performing an agglutination assay, (iv) performing a Western blot, a slot blot, or dot blot, or (v) running the sample through an analytical rotor.

4. The method of claim 1 , wherein said sample is a bodily fluid.

5. The method of claim 1 , wherein said sample is from a human, canine, or equine subject.

Assignments (3)
CHANGE OF NAME Recorded Feb 2, 2021
From: ABAXIS, INC.
To: ABAXIS LLC
Reel/Frame 055193/0637 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2021
From: ABAXIS LLC
To: ZOETIS SERVICES LLC
Reel/Frame 055193/0719 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2021
From: MEHRA, RAJESH K.; ARON, KENNETH P.; BLEILE, DENNIS M.; WALKER, JEREMY; CUESICO, CRISTINA
To: ABAXIS, INC.
Reel/Frame 054924/0790 →
Continuity (7)
Division 16126419 · Sep 10, 2018
Continuation 15684635 · Aug 23, 2017
Division 14924358 · Oct 27, 2015
Continuation 14304809 · Jun 13, 2014
Continuation 13667909 · Nov 2, 2012
Provisional Application 61556061 · Nov 4, 2011
Related Publication 20210140964A1 · May 13, 2021
Cited By (1)
US 12,638,446